MedTrace Logo

Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis

NCT02025699 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2017-01-13

No results posted yet for this study

Summary

The TAILORED-Treatment consortium was established to develop new tools aimed to increase the effectiveness of antibiotic and antifungal therapy, reduce adverse events, and help limit the emergence of antimicrobial resistance in children and adults.

Conditions

  • LRTI
  • Sepsis
  • Fungal Infections
  • Bacteremia
  • Fever Without Source

Sponsors & Collaborators

Principal Investigators

  • Kfir Oved, Dr. · MeMed Diagnostics Ltd.

Eligibility

Min Age
1 Month
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-06-30
Completion
2016-09-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02025699 on ClinicalTrials.gov